Inotuzumab Ozogamicin

62 interactions 4 explained in plain English
Also sold as: Besponsa
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Lefamulin Moxifloxacin Injection Mefloquine Deutetrabenazine Oxaliplatin Injection Olodaterol Oral Inhalation
62 Major
All (62) Major (62)

Major

Inotuzumab Ozogamicin Ketoconazole Topical Extina® Foam Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Lefamulin Xenleta Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Lenvatinib Lenvima Increased risk of QT-interval prolongation Details Inotuzumab Ozogamicin Levofloxacin Levaquin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Levofloxacin Injection Levaquin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) Details Inotuzumab Ozogamicin Mefloquine Lariam® Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Metronidazole Flagyl Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Metronidazole Injection Flagyl Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Metronidazole Topical MetroCream® Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Metronidazole Vaginal MetroGel® Vaginal Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Moxifloxacin Avelox Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Moxifloxacin Injection Avelox Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Moxifloxacin Ophthalmic Moxeza® Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Nafarelin Nasal Spray Synarel Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Octreotide Bynfezia Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Octreotide Injection Bynfezia Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Ofloxacin Floxin® Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Ofloxacin Ophthalmic Ocuflox Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Ofloxacin Otic Floxin® Otic Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Olodaterol Oral Inhalation Striverdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Inotuzumab Ozogamicin Oxaliplatin Injection Eloxatin® Increased risk of QT-interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.